HK Stock MarketDetailed Quotes

02616 CSTONE PHARMA-B

Watchlist
  • 1.950
  • -0.050-2.50%
Trading Nov 8 13:14 CST
2.50BMarket Cap-16115P/E (TTM)

CSTONE PHARMA-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:CNY
2024/H1
Stock NameRevenueRatio
Authorization fee income122.57M48.22%
Sale of drugs118.28M46.54%
Royalty income13.32M5.24%
Product

No Data

Region Currency:CNY
2024/H1
Stock NameRevenueRatio
China (excluding Hong Kong and Taiwan)232.11M91.32%
Switzerland16.04M6.31%
Other6.02M2.37%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data